The Oncology Institute, Inc. (STLN) — Defensive Interval Ratio
The Oncology Institute, Inc. (STLN) has a Defensive Interval Ratio of 255 days as of June 2026. Defensive assets of $66.35 Million (cash $-, short-term investments $-, receivables $66.35 Million) cover 255 days of daily cash needs of $260.11K/day. Check financial resilience of The Oncology Institute, Inc. to evaluate the company's liquid asset resilience ratio.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
The Oncology Institute, Inc. Defensive Interval Ratio (2022–2025)
This chart shows how The Oncology Institute, Inc.'s Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 255 days, meaning defensive assets of $66.35 Million can fund 255 days of operations without new revenue. See The Oncology Institute, Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Defensive Interval Ratio for The Oncology Institute, Inc. (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for The Oncology Institute, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see STLN total asset value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 303 days | $59.00 Million | $194.42K/day | $- | $- | ▼ -34 days |
| 2024 | 338 days | $48.34 Million | $143.05K/day | $- | $0.00 | ▼ -625 days |
| 2023 | 962 days | $91.73 Million | $95.31K/day | $- | $49.37 Million | ▼ -261 days |
| 2022 | 1223 days | $99.61 Million | $81.42K/day | $- | $59.80 Million | — |